Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
about
Parkinson's disease and CYP1A2 activityAssociation between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosisVariability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteersDopamine D2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat LiverClinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo bilobaThe effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women.Identification of a novel splice-site mutation in the CYP1A2 genePharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1.Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivoPhenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese populationThe effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake.Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.Non-linear fluvoxamine dispositionEffect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjectsChloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.
P2860
Q24564991-3BAA0467-885B-4FA6-92C7-74F1D54F6EC8Q24678827-CBDBBE22-1999-4769-9179-6BB3B0C2A750Q28365919-225D37AD-414F-47F1-9CCA-0FD6F4DA0B29Q28550244-981449AD-A081-4A2D-A246-7461A05DA47FQ35765836-AF006603-3134-4315-A141-13E10FFE93E4Q35804103-579EA422-E472-485A-A8A1-472E86BC824CQ35825664-B0F3B30E-E7A5-48BF-835C-11AB6F273048Q35825950-4F3D0EA5-843D-48DA-9A88-59B0936C6A79Q36053773-9A9DD343-E943-408D-92B2-F96FD9637BEFQ36055051-46AC28A1-5248-492C-A8A0-87A2751E5CFDQ36055087-C54FBEF2-AA26-4382-8354-713DC709BC29Q37315406-15C3EC5A-B1FB-40A7-B175-D055F8E2BA5DQ41469292-EFA21535-B121-4234-8F5A-FAD0A3D659BAQ41593416-0D0C4A21-784F-4875-8660-29C9FCD7626AQ41811711-2B9D4361-479B-4F12-8EB5-1E6876D28D99Q41906399-915BA9A9-B0D1-4FAC-993B-88DCFF8221C2Q41925505-BCA20032-4CCB-4680-89F5-CAC932B7DE4F
P2860
Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva.
@en
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva.
@nl
type
label
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva.
@en
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva.
@nl
prefLabel
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva.
@en
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva.
@nl
P1476
Simple and reliable CYP1A2 phe ...... ratio in plasma and in saliva
@en
P304
P356
10.1097/00008571-199406000-00001
P577
1994-06-01T00:00:00Z